ENGNW
enGene Holdings Inc. Warrants
NASDAQ · Healthcare · Biotechnology · CA
$0.21
−4.55%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.64x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.04x
- Price / sales
- —
- Price / cash flow
- -0.10x
Enterprise value
- Enterprise value
- -$214.4M
- EV / sales
- —
- EV / EBITDA
- 1.70x
- EV / EBIT
- 3.12x
- Market cap
- $10.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Apr 1, 2026